From: Serum anti-P53 antibodies and alpha-fetoprotein in patients with non-B non-C hepatocellular carcinoma
Anti P53 antibody + ve
Sensitivity
91.52%
Specificity
84.63%
PPV
90.34%
NPV
80.2%
Accuracy
74.8%